These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7867240)

  • 21. Study on the possible interaction between tenoxicam and atenolol in hypertensive patients.
    Hartmann D; Stief G; Lingenfelder M; Güzelhan C; Horsch AK
    Arzneimittelforschung; 1995 Apr; 45(4):494-8. PubMed ID: 7779149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind comparison of tiapamil and atenolol in patients with mild to moderate hypertension: a multicenter trial.
    Sykulski R; Keller N; Storm T; Stokke O; Myhre T; Himanen P; Quitzau K
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):427-31. PubMed ID: 2487539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of diltiazem and atenolol in angina.
    Wheatley D
    Postgrad Med J; 1985 Sep; 61(719):785-9. PubMed ID: 3903709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
    Pool PE; Seagren SC; Salel AF
    Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension. The Canadian Multicenter Diltiazem-CD Hypertension Trial Group.
    Ruddy TD; Wright JM; Savard D; Handa SP; Chockalingam A; Boulet AP
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):413-20. PubMed ID: 8527351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
    Ollivier JP; Wajman A; Stalla-Bourdillon A
    Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension.
    Houston MC; Olafsson L; Burger MC
    Angiology; 1991 Sep; 42(9):681-90. PubMed ID: 1928808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of amlodipine and long-acting diltiazem in the treatment of mild or moderate hypertension.
    Horwitz LD; Weinberger HD; Clegg L
    Am J Hypertens; 1997 Nov; 10(11):1263-9. PubMed ID: 9397246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable-threshold angina.
    Nadazdin A; Davies GJ
    Am Heart J; 1994 Feb; 127(2):312-7. PubMed ID: 8296698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
    Klein G; Berger J; Olsson G; Menzel T
    J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of once-daily atenolol and metoprolol using office and ambulatory blood pressure monitoring.
    Rutan GH; Feig PU; May S; Kriegman AG; Brady EM
    J Clin Pharmacol; 1993 May; 33(5):418-26. PubMed ID: 8331198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of felodipine ER and diltiazem SR as monotherapy in primary hypertension: a double-blind randomized study.
    Thulin T; Almkvist H; Berglund L; Björnsson T; Fagher B; Henningsen N; Honkavaara M; Naukkarinen V; Nordenström P; Sillanpää J
    Cardiovasc Drugs Ther; 1994 Dec; 8(6):845-9. PubMed ID: 7742263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diltiazem vs. nicardipine on ambulatory and exercise blood pressure and on peripheral hemodynamics.
    Palatini P; Casiglia E; Graniero GR; Dorigatti F; Lotoro F; Vriz O; Pessina AC
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):38-42. PubMed ID: 7711991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
    Thulin T; Hedner T; Gustafsson S; Olsson SO
    J Hum Hypertens; 1991 Apr; 5(2):107-14. PubMed ID: 2072368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
    Panfilov V; Morris AD; Donnelly R; Reid JL
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained-release diltiazem: duration of antihypertensive effect.
    Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; Dipette DJ; Evans RR
    J Clin Pharmacol; 1989 Jun; 29(6):533-7. PubMed ID: 2666454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, comparative, multicentric evaluation of atenolol/amlodipine combination with atenolol alone in essential hypertensive patients.
    Pareek A; Salkar H; Mulay P; Desai S; Chandurkar N; Redkar N
    Am J Ther; 2010; 17(1):46-52. PubMed ID: 19535971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.